Introduction

Exploring the recent FDA approvals of drugs like enforte map, pembrolizumab, and nivoleumab for metastatic urotheolial cancer, along with the evolution of treatment regimens for metastatic bladder cancer.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app